The single human musculoskeletal paper that gets cited often is a small retrospective case series of intra-articular BPC-157 injections for multiple types of knee pain. It reported improvement in 11 of 12 patients, but the study has major limitations: no control group, no standardized objective outcome measures, no imaging confirmation of pathology, and unclear diagnostic specificity
The amplitude activity of both the first and second neurons rose significantly
Endocrinology consultation is advisable when considering off-label combination therapy
Phase 4: adaptation and stabilization (weeks 28 and beyond) The decline in heart rate effects after week 24 reflects genuine physiological adaptation
Moreover, the side effects of these medications can be severe: pancreatitis, bowel obstruction, gastroparesis, nausea & vomiting, diarrhea as well as dietary insufficiencies